2023 annual financial data
INmune Bio 2023 Net margin
Direct answer
Net margin was -19,360%.
Operating income was -29,741,000 USD and net income was -30,008,000 USD.
Operating cash flow was -11,980,000 USD.
Get free INmune Bio email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 155,000 USD
- Operating income
- -29,741,000 USD
- Net income
- -30,008,000 USD
- Operating cash flow
- -11,980,000 USD